Although EGFR mutation is rare in ESCC, frequency of EGFR amplification or copy number variation (CNV) ranges from 6 to 24.3% [5–9], suggesting a potential for EGFR-targeted therapy in ESCC. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.